Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
12/2009
12/08/2009US7629475 kappa opioid receptors agonist; antidepressants for treating mood disorders, such as depressive disorders and manic disorders, psychological disorders
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/03/2009US20090299014 3,4-Dicarboxy-1,2,3,4-tetrahydro-6-t-butyl-1-naphthalene-succinic Dianhydride and Liquid Crystal Aligning Agent Comprising Polyimide Resin Prepared from the Dianhydride
12/02/2009CN101591333A Method for purifying pseudomonas acid A
12/02/2009CN100563648C Composition for oral administration containing alkylene dioxybenzene derivative
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009CA2521258C 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
11/2009
11/26/2009WO2009143049A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009WO2009142571A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009140887A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009WO2009140886A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009WO2009123948A3 Compounds and compositions as itpkb inhibitors
11/26/2009WO2009115557A3 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291212 VOLATILE METAL COMPLEXES OF PERFLUORO-tert-BUTANOL
11/26/2009CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009CA2724508A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009CA2724426A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009EP2121717A2 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use
11/25/2009EP2121608A1 Dihydropyridine derivatives useful as protein kinase inhibitors
11/25/2009EP2120567A1 Prodrugs of substituted 1,3-dioxanes and their uses
11/25/2009EP1828172B1 Pyrrole derivatives having crth2 receptor antagonist activity
11/25/2009CN100562518C Novel arylethene-sulfonamides compounds
11/24/2009CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/19/2009WO2009103007A3 Steroid hormone receptor modulator compounds and methods
11/19/2009US20090286780 2-oxochromene derivatives
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090283758 Organic semiconductor, photoelectric conversion element and image device
11/18/2009EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009CN101583603A Aromatic 1,4-di-carboxylamides and their use
11/18/2009CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/17/2009US7619102 Precipitation from aqueous solution; recovering precipitate; dissolving precipitate in solvent
11/17/2009US7619100 Physiologically active substances
11/12/2009WO2009137339A2 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136668A1 Chromene compound
11/12/2009WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009WO2009135944A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009US20090281175 Avermectin compounds and treatment of dermatological disorders in humans therewith
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009CA2722805A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/11/2009EP2116542A1 Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
11/11/2009CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/11/2009CN101575335A Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof
11/11/2009CN100558354C Triptolide lactone ring derivatives as immunomodulators and anticancer agents
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/05/2009WO2009133269A1 Novel diomestine derivatives, method for preparing same and pharmaceutical compositions containing same
11/05/2009WO2009133110A1 Modulators of dopamine neurotransmission
11/05/2009US20090275756 2-oxetanone derivative and process for production thereof
11/05/2009US20090272295 Coating Materials Consisting of Low- or Medium-Molecular Organic Compounds
11/05/2009CA2722986A1 Modulators of dopamine neurotransmission
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
10/2009
10/29/2009WO2009132202A2 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009WO2009131246A1 Sordarin derivatives for preventing or treating infectious diseases caused by pathogenic microorganisms
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009CA2722326A1 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009EP2111398A2 Spirocyclic tetronic acid derivatives
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009CN101568536A 2-aza-bicyclo[3.1.0]hexane derivatives
10/28/2009CN101565419A 7 and 20 dehydro-silybin dialky ether and preparation method and medicine use thereof
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/27/2009CA2564020C 6-o-substituted ketolides having antibacterial activity
10/27/2009CA2520813C Sustained release formulations of alkylene dioxybenzene derivatives useful as 5-ht1a agonists
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/22/2009WO2009127544A1 Pyridazinone glucokinase activators
10/22/2009WO2008110355A8 Quinoline derivatives as fungicides
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009CA2720559A1 Pyridazinone glucokinase activators
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101560208A Preparation method of pranlukast
10/21/2009CN101560201A Technique for extracting high purity puerarin and diverse rare medical components from root of kudzuvine
10/21/2009CN100551907C Compound in category of aryl methylamino dithio formic ether, preparation method and application
10/20/2009US7605277 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009CA2368993C C7 ester substituted taxanes as antitumor agents
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124638A1 Glucopyranoside derivatives
10/15/2009US20090259055 Catalytic enantioselective synthesis of flavanones and chromanones
10/15/2009US20090258905 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/15/2009CA2720586A1 Glucopyranoside derivatives
10/14/2009EP2108650A1 Novel aureothin derivatives
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
10/14/2009CN101558040A Dihydropyridine derivatives useful as protein kinase inhibitors
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 120